Testosterone Physiology, Diagnosis & Treatment: Hypogonadotropic Hypogonadism in a Young Male

Clinical Interpretation

Part 1 — Testosterone Physiology

1.1 Synthesis

• Cholesterol desmolase (rate-limiting; activated by LH)
• 17α-hydroxylase
• 17,20-lyase
• 3β-hydroxysteroid dehydrogenase
• 17β-hydroxysteroid dehydrogenase — unique to testes; converts androstenedione to testosterone

Fig. Testosterone biosynthesis — Costanzo Physiology, 7th Ed.

1.2 Transport

1.3 Mechanism of Action

1.4 The HPG Axis (Hypothalamic-Pituitary-Gonadal Axis)

Fig. HPG axis control — Costanzo Physiology, 7th Ed.

1.5 Actions of Testosterone

Part 2 — Diagnosis

2.1 Clinical Classification

2.2 Most Likely Diagnoses

A. Kallmann Syndrome / Congenital Hypogonadotropic Hypogonadism (CHH)

• Caused by GnRH neuron migration failure during embryogenesis — GnRH neurons arise from the olfactory placode and fail to migrate to the hypothalamus
• Associated with anosmia or hyposmia (Kallmann) or normal smell (normosmic CHH)
• Genetic causes include mutations in: ANOS1 (KAL1), FGFR1, FGF8, PROKR2, CHD7, and many others (Harrison's 22E)
• Phenotype: small testes, absent/reduced secondary sexual characteristics, eunuchoid proportions, cryptorchidism possible; beard and pubic hair may be partially present from adrenal androgens

B. Klinefelter Syndrome (47,XXY) — Primary Hypogonadism

• Most common chromosomal cause of male hypogonadism (1 in 600 males)
• Small firm testes, gynecomastia, tall stature, azoospermia
• LH and FSH are elevated (distinguishes it from CHH)
• Less likely here given no gynecomastia is mentioned and normal beard, but karyotype should be checked

2.3 Diagnostic Workup

• Total testosterone (morning fasting, 8–10 AM; confirm on two separate occasions if borderline)
• Normal adult male range: ~300–1000 ng/dL (10.4–34.7 nmol/L)
• If low, proceed to Step 2

• LH and FSH:
  • Low/normal LH + low T → Secondary (hypogonadotropic) hypogonadism
  • High LH + low T → Primary (hypergonadotropic) hypogonadism
• SHBG and free testosterone if SHBG suspected to be elevated

Part 3 — Treatment

3.1 If Fertility Is NOT Currently Desired — Testosterone Replacement Therapy (TRT)

• Libido restored within 3–6 weeks
• Morning erections return
• Muscle mass increases over 3–6 months
• Energy, mood improve
• Bone density increases over 12–24 months

• Testosterone levels (trough before injection; mid-cycle for gels)
• Hematocrit (target <54%; TRT raises RBC count)
• PSA (not relevant at 23, but baseline useful)
• Testicular size (may atrophy further — warn patient)
• Fertility: TRT suppresses FSH/LH and will impair spermatogenesis — must counsel before starting

3.2 If Fertility IS Desired — Gonadotropin Therapy

3.3 Novel/Emerging Options

Summary Algorithm

23-yr male: low libido, no morning erections, poor muscle mass
                        ↓
            Morning testosterone (×2 confirmed)
                        ↓
                    LOW (<300 ng/dL)
                        ↓
              Check LH + FSH
            ↙                    ↘
    LH/FSH LOW or                  LH/FSH HIGH
    inappropriately normal          (>10 IU/L)
           ↓                              ↓
  Secondary Hypogonadism         Primary Hypogonadism
  (CHH / Kallmann / pituitary)   (Klinefelter; orchitis)
           ↓                              ↓
    MRI pituitary                   Karyotype
    Olfactory testing               Testicular USS
    Prolactin
           ↓
  Fertility desired?
  YES → hCG ± FSH / GnRH pump
  NO  → Testosterone replacement

Key References

• Costanzo Physiology, 7th Ed. — Testosterone synthesis, HPG axis, negative feedback
• Guyton & Hall Textbook of Medical Physiology — Testosterone actions, hypogonadism
• Harrison's Principles of Internal Medicine 22E (2025) — Hypogonadotropic hypogonadism, Kallmann syndrome, TRT
• Goldman-Cecil Medicine — Male hypogonadism classification and management
• Hohl A et al. (2025). Clomiphene or enclomiphene for male hypogonadism. Arch Endocrinol Metab. [PMID: 41066380]